The healthcare landscape for diabetes is shifting, and transdermal GLP-1 delivery systems represent a exciting breakthrough. Unlike shots, this approach offers a less invasive way to administer GLP-1 drugs. These devices gradually release the treatment through the skin offering a even dose of the